NCT06239441View on ClinicalTrials.gov

Effectiveness of Anti-IL-5/IL5R Inhibitors

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

June 13, 2023

Study Completion Date

November 29, 2023

Conditions
Severe Asthma
Interventions
DRUG

IL5/IL5R Antagonists

Treatment with IL5/IL5R antagonists for one year

Trial Locations (1)

HJ1C5

Hôpital du Sacré-Coeur de Montréal, Montreal

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER